Breaking News Instant updates and real-time market news.

2020-12-18 09:08:58 DSX Diana Shipping $2.00 / -0.015 (-0.74%) 09:08 12/18/20 12/18 09:08 12/18/20 09:08	Diana Shipping announces sale of m/v Oceanis, contract for m/v New York Diana Shipping announced that it has signed, through a separate wholly-owned subsidiary, a Memorandum of Agreement to sell to an unaffiliated third party, the 2001-built vessel "Oceanis", with delivery to the buyer latest by April 16, 2021, for a sale price of $5.75M before commissions. The Company also announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with EGPN Bulk Carrier Co., Limited, Hong Kong, for one of its Capesize dry bulk vessels, the m/v New York. The gross charter rate is $14,000 per day, minus a 5% commission paid to third parties, for a period until minimum April 16, 2022 up to maximum June 30, 2022. The charter is expected to commence on December 27, 2020. The "New York" is a 177,773 dwt Capesize dry bulk vessel built in 2010. This employment is anticipated to generate approximately $6.57M of gross revenue for the minimum scheduled period of the time charter.
DSX Diana Shipping $2.00 / -0.015 (-0.74%) 09/08/20 Pareto Diana Shipping downgraded to Hold from Buy at Pareto 06/17/20 Fly Intel: Top five analyst upgrades 06/17/20 Pareto Diana Shipping upgraded to Buy from Hold at Pareto 04/01/20 Pareto Diana Shipping upgraded to Hold from Sell at Pareto

2020-12-18 09:08:58

DSX

Diana Shipping

$2.00 / -0.015 (-0.74%)

09:08

12/18/20

12/18

09:08

12/18/20

09:08

Diana Shipping announces sale of m/v Oceanis, contract for m/v New York

Diana Shipping announced that it has signed, through a separate wholly-owned subsidiary, a Memorandum of Agreement to sell to an unaffiliated third party, the 2001-built vessel "Oceanis", with delivery to the buyer latest by April 16, 2021, for a sale price of $5.75M before commissions. The Company also announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with EGPN Bulk Carrier Co., Limited, Hong Kong, for one of its Capesize dry bulk vessels, the m/v New York. The gross charter rate is $14,000 per day, minus a 5% commission paid to third parties, for a period until minimum April 16, 2022 up to maximum June 30, 2022. The charter is expected to commence on December 27, 2020. The "New York" is a 177,773 dwt Capesize dry bulk vessel built in 2010. This employment is anticipated to generate approximately $6.57M of gross revenue for the minimum scheduled period of the time charter.

DSX Diana Shipping

$2.00 / -0.015 (-0.74%)

09/08/20 Pareto: Diana Shipping downgraded to Hold from Buy at Pareto

06/17/20: Fly Intel: Top five analyst upgrades

06/17/20 Pareto: Diana Shipping upgraded to Buy from Hold at Pareto

04/01/20 Pareto: Diana Shipping upgraded to Hold from Sell at Pareto

TODAY'S FREE FLY STORIES

Earnings	New Oriental Education reports Q2 EPS 43c, consensus 34c » 05:29 01/22/21 01/22 05:29 01/22/21 05:29 EDU New Oriental Education $182.75 / +11.46 (+6.69%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events EDU New Oriental Education $182.75 / +11.46 (+6.69%) 01/18/21 New Oriental Education names CFO Zhihui Yang Executive President EDU New Oriental Education $182.75 / +11.46 (+6.69%) 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 12/28/20 Citi Citi keeps 'long-term positive stance' on New Oriental Education 11/30/20 CLSA New Oriental Education weakness a buying opportunity, says CLSA 11/25/20 Morgan Stanley OneSmart downgraded to Equal Weight on margin pressure at Morgan Stanley EDU New Oriental Education $182.75 / +11.46 (+6.69%) 10/13/20 New Oriental Education sees Q2 revenue $863.7M-$887.3M, consensus $860.5M 10/13/20 New Oriental Education reports Q1 EPS $1.15, consensus $1.01 07/28/20 New Oriental Education sees Q3 revenue $911.2M-$953.5M, consensus $1.09B 07/28/20 New Oriental Education reports Q2 EPS 30c, consensus 35c EDU New Oriental Education $182.75 / +11.46 (+6.69%) 08/07/20 Citon says authorities given info to end GSX Techedu 'charade' 08:00 Today New Oriental Education - EDU
Downgrade	TAL Education downgraded to Neutral from Outperform at Credit Suisse » 05:29 01/22/21 01/22 05:29 01/22/21 05:29 TAL TAL Education $78.02 / +10.29 (+15.19%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options TAL TAL Education $78.02 / +10.29 (+15.19%) 01/21/21 TAL Education rises 13.8% 12/28/20 TAL Education announces $3.3B private placement with Silver Lake-led investors TAL TAL Education $78.02 / +10.29 (+15.19%) 12/30/20 Credit Suisse Credit Suisse cuts TAL target to $79 on margin pressure from online competition 12/29/20 CLSA TAL Education now has 'war chest' to fight competition, says CLSA 11/25/20 Morgan Stanley OneSmart downgraded to Equal Weight on margin pressure at Morgan Stanley 10/26/20 JPMorgan TAL Education downgraded to Neutral from Overweight at JPMorgan (Friday) TAL TAL Education $78.02 / +10.29 (+15.19%) 01/21/21 TAL Education sees Q4 revenue $1.18B-$1.2B, consensus $1.17B 01/21/21 TAL Education reports Q3 EPS 2c, consensus 7c 10/22/20 TAL Education sees Q3 revenue $1.06B-$1.09B, consensus $1.14B 10/22/20 TAL Education reports Q2 EPS 8c, consensus 12c TAL TAL Education $78.02 / +10.29 (+15.19%) 08/07/20 Citon says authorities given info to end GSX Techedu 'charade' TAL TAL Education $78.02 / +10.29 (+15.19%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday TAL TAL Education $78.02 / +10.29 (+15.19%) 09/03/20 Tal Education Group put volume heavy and directionally bearish
Upgrade	dormakaba upgraded to Neutral from Reduce at Oddo BHF » 05:28 01/22/21 01/22 05:28 01/22/21 05:28 DRRKF dormakaba $0.00 / + (+0.00%) Oddo BHF analyst Delphine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DRRKF dormakaba $0.00 / + (+0.00%) 12/16/20 Credit Suisse dormakaba price target lowered to CHF 600 from CHF 660 at Credit Suisse 08/20/20 Kepler Cheuvreux dormakaba upgraded to Hold from Reduce at Kepler Cheuvreux 06/24/20 HSBC dormakaba downgraded to Reduce from Hold at HSBC 04/09/20 UBS dormakaba upgraded to Neutral from Sell at UBS
Upgrade	Legrand upgraded to Buy from Neutral at Oddo BHF » 05:27 01/22/21 01/22 05:27 01/22/21 05:27 LGRVF Legrand $0.00 / + (+0.00%) Oddo BHF analyst Delphine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LGRVF Legrand $0.00 / + (+0.00%) 10/20/20 Jefferies Legrand upgraded to Hold from Underperform at Jefferies 03/30/20 Exane BNP Paribas Legrand upgraded to Outperform from Neutral at Exane BNP Paribas
Downgrade	Kone OYJ downgraded to Neutral from Buy at Oddo BHF » 05:27 01/22/21 01/22 05:27 01/22/21 05:27 KNYJY Kone OYJ $0.00 / + (+0.00%) Oddo BHF analyst Delphine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KNYJY Kone OYJ $0.00 / + (+0.00%) 01/13/21 Barclays Kone OYJ price target lowered to EUR 58 from EUR 60 at Barclays 12/10/20 Kepler Cheuvreux Kone OYJ upgraded to Buy from Hold at Kepler Cheuvreux 12/07/20 JPMorgan Kone OYJ price target raised to EUR 75 from EUR 74 at JPMorgan 12/01/20 Exane BNP Paribas Kone OYJ downgraded to Neutral from Outperform at Exane BNP Paribas

Downgrade	Schindler downgraded to Reduce from Neutral at Oddo BHF » 05:27 01/22/21 01/22 05:27 01/22/21 05:27 SHLAF Schindler $0.00 / + (+0.00%) Oddo BHF analyst Delphine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SHLAF Schindler $0.00 / + (+0.00%) 01/13/21 Barclays Schindler price target lowered to CHF 210 from CHF 220 at Barclays 12/10/20 Kepler Cheuvreux Schindler downgraded to Hold from Buy at Kepler Cheuvreux 12/08/20 Commerzbank Schindler initiated with a Reduce at Commerzbank 12/01/20 Exane BNP Paribas Schindler downgraded to Underperform from Neutral at Exane BNP Paribas
Downgrade	DBV Technologies downgraded to Sell from Hold at Societe Generale » 05:25 01/22/21 01/22 05:25 01/22/21 05:25 DBVT DBV Technologies $6.51 / +0.02 (+0.31%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly DBVT DBV Technologies $6.51 / +0.02 (+0.31%) 01/15/21 DBV Technologies gets feedback from FDA regarding Viaskin Peanut regulatory path 01/07/21 DBV Technologies restructuring plan to result in reduction of over 200 jobs 11/24/20 DBV Technologies CSO Hugh Sampson to step down from role 11/02/20 DBV Technologies receives validation for Viaskin Peanut MAA by EMA DBVT DBV Technologies $6.51 / +0.02 (+0.31%) 01/18/21 Goldman Sachs DBV Technologies price target raised to $7 from $4 at Goldman Sachs 01/15/21 Citi DBV Technologies price target raised to $8 from $4 at Citi 01/15/21 H.C. Wainwright DBV now has 'clear developmental path,' says H.C. Wainwright 11/02/20 Societe Generale DBV Technologies upgraded to Hold on improved visibility at Societe Generale DBVT DBV Technologies $6.51 / +0.02 (+0.31%) 07/31/20 DBV Technologies reports first half EPS EUR (1.62) vs. EUR (2.43) last year 30 Jan DBVT DBV Technologies $6.51 / +0.02 (+0.31%) 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Fly Intel: Wall Street's top stories at midday 01/15/21 Fly Intel: Pre-market Movers 11/02/20 Fly Intel: Pre-market Movers
Initiation	Sage Group initiated with a Buy at Peel Hunt » 05:24 01/22/21 01/22 05:24 01/22/21 05:24 SGPYY Sage Group $0.00 / + (+0.00%) Peel Hunt analyst Damindu… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SGPYY Sage Group $0.00 / + (+0.00%) 01/14/21 Sage Group says AgeMark moves to Sage Intacct solution 12/16/20 Sage announces Sage Partner Cloud Program in the U.S., Canada SGPYY Sage Group $0.00 / + (+0.00%) 01/11/21 Canaccord Sage Group price target lowered to 680 GBp from 700 GBp at Canaccord 12/10/20 Morgan Stanley Sage Group upgraded to Equal Weight from Underweight at Morgan Stanley 11/25/20 JPMorgan Sage Group price target lowered to 560 GBp from 600 GBp at JPMorgan 11/24/20 UBS Sage Group price target lowered to 550 GBp from 610 GBp at UBS
Downgrade	Gerresheimer downgraded to Hold from Buy at Pareto » 05:22 01/22/21 01/22 05:22 01/22/21 05:22 GRRMF Gerresheimer $0.00 / + (+0.00%) Pareto analyst Zafer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GRRMF Gerresheimer $0.00 / + (+0.00%) 07/29/20 Berenberg Gerresheimer price target raised to EUR 115 from EUR 75 at Berenberg
Downgrade	Siltronic downgraded to Neutral from Buy at Oddo BHF » 05:21 01/22/21 01/22 05:21 01/22/21 05:21 SSLLF Siltronic $0.00 / + (+0.00%) Oddo BHF analyst Stephane… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SSLLF Siltronic $0.00 / + (+0.00%) 01/12/21 Deutsche Bank Siltronic price target raised to EUR 150 from EUR 135 at Deutsche Bank 12/11/20 Jefferies Siltronic downgraded to Hold from Buy at Jefferies 12/04/20 UBS Siltronic price target raised to EUR 125 from EUR 85 at UBS 12/02/20 Berenberg Siltronic price target raised to EUR 125 from EUR 85 at Berenberg

Upgrade	Carl Zeiss Meditec upgraded to Hold from Sell at DZ Bank » 05:20 01/22/21 01/22 05:20 01/22/21 05:20 CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) DZ Bank analyst Sven… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 10/07/20 Microsoft, Zeiss announce multi-year strategic partnership CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 01/20/21 Berenberg Carl Zeiss Meditec price target raised to EUR 127 from EUR 87 at Berenberg 01/20/21 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 140 from EUR 120 at Deutsche Bank 11/02/20 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 120 from EUR 110 at Deutsche Bank 10/23/20 UBS Carl Zeiss Meditec downgraded to Neutral from Buy at UBS
Upgrade	Ericsson upgraded to Buy from Hold at Nordea » 05:19 01/22/21 01/22 05:19 01/22/21 05:19 ERIC Ericsson $11.77 / -0.08 (-0.68%) Nordea analyst Sami… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events Options ERIC Ericsson $11.77 / -0.08 (-0.68%) 01/13/21 T-Mobile announces five-year agreements with Ericsson, Nokia 12/17/20 Nokia appoints Nishant Batra as chief strategy, technology officer 12/17/20 Veoneer CTO Nishant Batra to leave for Nokia, Giuseppe Rosso named acting CTO 11/10/20 Ericsson announces new long-term financial targets at Capital Markets Day ERIC Ericsson $11.77 / -0.08 (-0.68%) 01/14/21 Barclays Ericsson price target lowered to SEK 120 from SEK 125 at Barclays 11/20/20 UBS Ericsson price target raised to SEK 102 from SEK 86 at UBS 11/12/20 Societe Generale Ericsson upgraded to Buy from Hold at Societe Generale 10/22/20 Barclays Ericsson price target raised to SEK 125 from SEK 110 at Barclays ERIC Ericsson $11.77 / -0.08 (-0.68%) 10/21/20 Ericsson reports Q3 EPS SEK 1.61 vs. (SEK 1.89) last year ERIC Ericsson $11.77 / -0.08 (-0.68%) 01/08/21 Samsung files ITC case to block Ericsson 5G imports, Bloomberg reports 10/20/20 Swedish regulators ban Huawei, ZTE from upcoming 5G networks, Reuters reports 02/11/21 Technology & Internet Virtual Conference 01/29/21 Ericsson - ERIC ERIC Ericsson $11.77 / -0.08 (-0.68%) 01/05/21 Unusually active option classes on open January 5th 11/10/20 Ericsson put volume heavy and directionally bearish 10/14/20 Ericsson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th
Downgrade	Syrah Resources downgraded to Neutral from Outperform at Credit Suisse » 05:18 01/22/21 01/22 05:18 01/22/21 05:18 SYAAF Syrah Resources $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Downgrade	Air France-KLM downgraded to Reduce from Hold at Kepler Cheuvreux » 05:18 01/22/21 01/22 05:18 01/22/21 05:18 AFLYY Air France-KLM $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals AFLYY Air France-KLM $0.00 / + (+0.00%) 12/04/20 KLM, Delta to offer COVID-19 tested flights from Atlanta to Amsterdam AFLYY Air France-KLM $0.00 / + (+0.00%) 01/20/21 Barclays Air France-KLM price target raised to EUR 5.10 from EUR 2.70 at Barclays 12/04/20 Deutsche Bank Air France-KLM price target raised to EUR 3.50 from EUR 2.10 at Deutsche Bank 12/01/20 UBS Air France-KLM price target raised to EUR 4.45 from EUR 3.35 at UBS 11/12/20 Kepler Cheuvreux Air France-KLM upgraded to Hold from Reduce at Kepler Cheuvreux AFLYY Air France-KLM $0.00 / + (+0.00%) 07/30/20 Air France-KLM sees 'significantly negative' EBITDA in second half 07/30/20 Air France-KLM reports Q2 revenue EUR 1.18B vs. EUR 7.02B last year AFLYY Air France-KLM $0.00 / + (+0.00%) 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports 09/24/20 KLM steps up labor talks aimed to securing wage cuts, Bloomberg reports 09/01/20 Air France-KLM plans to raise funds by May of next year, Bloomberg reports
Downgrade	Alstom downgraded to Hold from Buy at Kepler Cheuvreux » 05:17 01/22/21 01/22 05:17 01/22/21 05:17 ALSMY Alstom $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ALSMY Alstom $0.00 / + (+0.00%) 12/01/20 Bombardier, Alstom confirm receipt of all necessary approvals for transaction 09/16/20 Bombardier announces SPA for sale of transportation business to Alstom 07/31/20 European Commission clears Alstom's acquisition of Bombardier Transportation 07/28/20 Linde to begin construction on hydrogen refueling station for trains in Germany ALSMY Alstom $0.00 / + (+0.00%) 01/20/21 Jefferies Alstom upgraded to Buy from Hold at Jefferies 01/12/21 Deutsche Bank Alstom price target raised to EUR 47 from EUR 45 at Deutsche Bank 12/11/20 Credit Suisse Alstom upgraded to Outperform from Neutral at Credit Suisse 12/08/20 Morgan Stanley Alstom price target raised to EUR 55 from EUR 51 at Morgan Stanley ALSMY Alstom $0.00 / + (+0.00%) 07/27/20 EU set to approve with conditions Alstom, Bombardier deal, Reuters reports

Downgrade	IAG downgraded to Reduce from Hold at Kepler Cheuvreux » 05:17 01/22/21 01/22 05:17 01/22/21 05:17 ICAGY IAG $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ICAGY IAG $0.00 / + (+0.00%) 07/24/20 IAG 'evaluating the merits of a rights issue' of up to EUR 2.75B ICAGY IAG $0.00 / + (+0.00%) 01/20/21 Barclays IAG price target raised to 175 GBp from 120 GBp at Barclays 12/31/20 Fly Intel: Top five analyst calls 12/31/20 Citi IAG upgraded to Buy from Neutral at Citi 12/04/20 Deutsche Bank IAG price target raised to 220 GBp from 175 GBp at Deutsche Bank ICAGY IAG $0.00 / + (+0.00%) 12/07/20 IAG dismisses Ryanair comments on British Airways holding, Reuters says 11/05/20 British Airways to reduce flight schedule in November, Reuters reports
Upgrade	Adient upgraded to Neutral from Underweight at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 ADNT Adient $35.26 / -0.71 (-1.97%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ADNT Adient $35.26 / -0.71 (-1.97%) 08/14/20 Greenlight Capital exits Altice, takes stake in Atlas Air ADNT Adient $35.26 / -0.71 (-1.97%) 01/20/21 Deutsche Bank Adient price target raised to $43 from $37 at Deutsche Bank 12/17/20 Barclays Adient price target raised to $45 from $37 at Barclays 12/16/20 KeyBanc Adient price target raised to $43 from $36 at KeyBanc 12/02/20 Deutsche Bank Adient price target raised to $37 from $27 at Deutsche Bank ADNT Adient $35.26 / -0.71 (-1.97%) 11/30/20 Adient sees FY21 revenue $14.6B-$15B, consensus $14.47B 11/30/20 Adient reports Q4 adj. EPS $1.15, consensus 71c 08/06/20 Adient sees Q4 revenue $3.3B-$3.5B, consensus $3.31B 08/06/20 Adient reports Q3 adj. EPS ($2.78), consensus ($2.08) 02/05/21 Adient - ADNT
Downgrade	Gentherm downgraded to Underweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 THRM Gentherm $70.38 / -0.6 (-0.85%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings THRM Gentherm $70.38 / -0.6 (-0.85%) 01/11/21 Gentherm appoints Betsy Meter to board of directors 01/04/21 Gentherm appoints Steve Fletcher as SVP, GM of Medical 10/29/20 Gentherm to delay Q3 conference call 10/15/20 Gentherm launches ASTOPAD Patient Warming System THRM Gentherm $70.38 / -0.6 (-0.85%) 12/23/20 Barrington Gentherm double downgraded to Underperform at Barrington following rally 12/23/20 Barrington Gentherm downgraded to Underperform from Outperform at Barrington 10/30/20 Roth Capital Gentherm price target raised to $53 from $44 at Roth Capital 10/22/20 JPMorgan Gentherm price target raised to $48 from $43 at JPMorgan THRM Gentherm $70.38 / -0.6 (-0.85%) 10/29/20 Gentherm sees Q4 product revenues $240M-$260M, consensus $228.41M 10/29/20 Gentherm reports Q3 adjusted EPS 91c, consensus 49c 08/04/20 Gentherm not providing update to FY20 guidance 08/04/20 Gentherm sees Q3 product revenues $210M-$240M, consensus $212.53M
Upgrade	Lear upgraded to Overweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 LEA Lear $168.15 / +0.79 (+0.47%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LEA Lear $168.15 / +0.79 (+0.47%) 01/14/21 Cerence, Xevo collaborate for to deliver Cerence Pay payment capabilities 01/11/21 Lear partners with GrubHub to deliver ordering capabilities in FCA vehicles 11/18/20 Lear reinstates quarterly cash dividend at 25c per share 11/16/20 Paulson & Co. buys Lear, cuts Tiffany in Q3 LEA Lear $168.15 / +0.79 (+0.47%) 01/20/21 Deutsche Bank Lear price target raised to $165 from $150 at Deutsche Bank 01/08/21 Guggenheim Lear downgraded to Neutral from Buy at Guggenheim 12/17/20 Barclays Lear upgraded to Overweight from Equal Weight at Barclays 12/16/20 Argus Lear upgraded to Buy at Argus on high expected demand following COVID LEA Lear $168.15 / +0.79 (+0.47%) 10/30/20 Lear reinstates FY20 revenue view $16.35B-$16.65B, consensus $16.45B 10/30/20 Lear reports Q3 adj. EPS $3.73, consensus $3.14 08/04/20 Lear not providing FY20 guidance due to COVID-19 08/04/20 Lear reports Q2 adj. EPS ($4.14), consensus ($4.67) LEA Lear $168.15 / +0.79 (+0.47%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 02/04/21 Lear - LEA
Downgrade	Visteon downgraded to Underweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 VC Visteon $142.17 / +0.6 (+0.42%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VC Visteon $142.17 / +0.6 (+0.42%) 12/07/20 Cognex names Visteon CEO Lawande to board of directors VC Visteon $142.17 / +0.6 (+0.42%) 01/20/21 Deutsche Bank Visteon price target raised to $166 from $105 at Deutsche Bank 12/17/20 Barclays Visteon price target raised to $150 from $101 at Barclays 11/19/20 Baird Visteon price target raised to $130 from $105 at Baird 11/03/20 Goldman Sachs Visteon upgraded to Neutral from Sell at Goldman Sachs VC Visteon $142.17 / +0.6 (+0.42%) 10/29/20 Visteon reports Q3 adjusted EPS $1.36, consensus 50c 07/30/20 Visteon reports Q2 EPS ($1.62), consensus ($2.12)

Downgrade	Aptiv downgraded to Neutral from Overweight at JPMorgan » 05:15 01/22/21 01/22 05:15 01/22/21 05:15 APTV Aptiv $143.95 / -1.16 (-0.80%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly Events APTV Aptiv $143.95 / -1.16 (-0.80%) 01/20/21 Deutsche Bank Aptiv price target raised to $160 from $120 at Deutsche Bank 12/22/20 Citi Citi 'very skeptical' of Apple car, says Tesla most direct competitor 12/17/20 Barclays Aptiv price target raised to $145 from $112 at Barclays 12/16/20 Argus Aptiv initiated with a Buy at Argus on 'attractive valuation' APTV Aptiv $143.95 / -1.16 (-0.80%) 10/29/20 Aptiv sees FY20 adj. EPS $1.65-$1.80, consensus $1.28 10/29/20 Aptiv reports Q3 ex-items EPS $1.13, consensus 76c 07/30/20 Aptiv not reporting Q3, FY20 guidance at this time 07/30/20 Aptiv reports Q2 EPS ex-items ($1.10), consensus ($1.38) 10 Jun APTV Aptiv $143.95 / -1.16 (-0.80%) 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/22/20 Apple rises as Wall Street digests report of self-driving car plans 09/18/20 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/03/21 Aptiv - APTV
Downgrade	TGS-NOPEC downgraded to Sell from Neutral at UBS » 05:15 01/22/21 01/22 05:15 01/22/21 05:15 TGSGY TGS-NOPEC $0.00 / + (+0.00%) UBS analyst Amy Wong… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TGSGY TGS-NOPEC $0.00 / + (+0.00%) 10/09/20 UBS TGS-NOPEC price target lowered to NOK 135 from NOK 145 at UBS 10/09/20 DNB Markets TGS-NOPEC downgraded to Sell from Hold at DNB Markets 10/09/20 Danske Bank TGS-NOPEC downgraded to Hold from Buy at Danske Bank 08/19/20 Fearnley TGS-NOPEC downgraded to Sell from Buy at Fearnley
Downgrade	Bunzl downgraded to Equal Weight from Overweight at Barclays » 05:14 01/22/21 01/22 05:14 01/22/21 05:14 BZLFF Bunzl $0.00 / + (+0.00%) Barclays analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Downgrade	Vifor Pharma downgraded to Sell from Neutral at UBS » 05:13 01/22/21 01/22 05:13 01/22/21 05:13 GNHAF Vifor Pharma / + UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNHAF Vifor Pharma / + 11/09/20 Vifor Pharma, Angion sign licensing agreement for ANG-3777 commercialization 10/20/20 Vifor Pharma, Cara Therapeutics enter license agreement for Korsuva Injection GNHAF Vifor Pharma / + 05:13 Today UBS Vifor Pharma downgraded to Sell from Neutral at UBS 01/04/21 JPMorgan Vifor Pharma downgraded to Underweight from Neutral at JPMorgan 10/22/20 Credit Suisse Vifor Pharma price target lowered to CHF 149 from CHF 152 at Credit Suisse 10/21/20 JPMorgan Vifor Pharma price target lowered to CHF 130 from CHF 175 at JPMorgan
Downgrade	Vifor Pharma downgraded to Sell from Neutral at UBS » 05:13 01/22/21 01/22 05:13 01/22/21 05:13 GNHAF Vifor Pharma $0.00 / + (+0.00%) UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GNHAF Vifor Pharma $0.00 / + (+0.00%) 11/09/20 Vifor Pharma, Angion sign licensing agreement for ANG-3777 commercialization 10/20/20 Vifor Pharma, Cara Therapeutics enter license agreement for Korsuva Injection GNHAF Vifor Pharma $0.00 / + (+0.00%) 01/04/21 JPMorgan Vifor Pharma downgraded to Underweight from Neutral at JPMorgan 10/22/20 Credit Suisse Vifor Pharma price target lowered to CHF 149 from CHF 152 at Credit Suisse 10/21/20 JPMorgan Vifor Pharma price target lowered to CHF 130 from CHF 175 at JPMorgan 10/21/20 UBS Vifor Pharma price target lowered to CHF 129 from CHF 142 at UBS

Events

Earnings calls, analyst events, roadshows and more

TBK
Today at 08:00

Triumph Bancorp - TBK Conference Calls
PPG
Today at 08:00

PPG - PPG Conference Calls
EDU
Today at 08:00

New Oriental Education - EDU Conference Calls
HBAN
Today at 08:30

Huntington Bancshares - HBAN Conference Calls
SLB
Today at 08:30

Schlumberger - SLB Conference Calls
BMTC
Today at 08:30

Bryn Mawr Bank - BMTC Conference Calls
KSU
Today at 08:45

Kansas City Southern - KSU Conference Calls
ALLY
Today at 09:00

Ally Financial - ALLY Conference Calls
TRST
Today at 09:00

Trustco Bank - TRST Conference Calls
DNMR
Today at 09:00

Danimer Scientific - DNMR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley $4.75-4.95 11.5M Shares PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities $13.00-14.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright $7.50-8.00 SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright $2.42 25.974M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Diana Shipping announces sale of m/v Oceanis, contract for m/v New York

TODAY'S FREE FLY STORIES

Get Full Fly Access